Drug Eluting Balloons will Drug-Eluting Balloons ... - summitMD.com

More documents

Recommendations

Info

(2) Mechanism of Action of DCB Sustained Tissue Retention of Paclitaxel Transit Drug Loss DCB Acute Drug Transfer TISSUE LEVEL ENDPOINTS • Below toxic threshold • Homogeneous distribution • Sustained therapeutic levels l Acute Drug Transfer Drug Transfer Technology
Deposition of a Drug Delivery Biofilm Proposed Mechanism of Action Cotavance DCB Technology Localized endovascular retention of paclitaxel particles serving as a reservoir for sustained drug delivery Histology picture obtained from CVPath
Page 1 and 2: Drug-Eluting Balloons will Have an
Page 3 and 4: Drug Coated Balloon Technologies A
Page 5 and 6: PCB for the Treatment of ISR Angiog
Page 7 and 8: Clinical Outcomes Among 250 Patient
Page 9 and 10: PCB for the Treatment of De Novo SF
Page 11 and 12: Vascular Healing Following PCB Use
Page 13 and 14: Synergistic Use of PCB and BMS Less
Page 15: (1) Systemic Release of Paclitaxel
Page 19 and 20: (3) Local Tissue Effects (Safety) V
Page 21: Conclusions: PCB Technologies • P

Drug Eluting Balloons will Drug-Eluting Balloons ... - summitMD.com

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?